Akebia Therapeutics, Inc. (AKBA) Social Stream



Akebia Therapeutics, Inc. (AKBA): $2.85

-0.07 (-2.40%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add AKBA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 504

in industry

Akebia Therapeutics Inc (AKBA) Price Targets From Analysts

Use the tables below to see what analysts covering Akebia Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
7 $10 $2.76 $6.54 $2.92 123.97%

The Trend in the Analyst Price Target


AKBA's average price target has moved down $10.58 over the prior 17 months.

AKBA reports an average of 107.66% for its upside potential over the past 17 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-20 7 10 2.76 6.54 2.800 133.57%
2021-09-19 7 10 2.76 6.54 2.900 125.52%
2021-09-18 7 10 2.76 6.54 2.900 125.52%
2021-09-03 7 10 2.76 6.54 3.030 115.84%
2021-08-28 7 10 2.76 6.54 2.850 129.47%
2021-08-14 7 10 2.76 6.54 2.520 159.52%
2021-07-06 7 10 3.00 6.57 3.510 87.18%
2021-07-03 7 10 3.00 6.57 3.710 77.09%
2021-06-26 7 10 3.00 6.57 4.200 56.43%
2021-05-28 7 10 3.00 6.57 3.510 87.18%
2021-05-22 7 10 3.00 6.57 3.490 88.25%
2021-05-15 7 10 3.00 6.57 3.450 90.43%
2021-05-08 7 10 3.00 6.71 3.120 115.06%
2021-04-15 7 10 3.00 6.71 3.060 119.28%
2021-04-10 7 10 3.00 6.71 3.060 119.28%
2021-04-03 7 10 3.00 6.71 3.330 101.5%
2021-03-08 6 10 3.00 7.00 3.330 110.21%
2021-03-06 6 10 3.00 7.00 3.405 105.58%
2021-02-27 6 10 3.00 7.00 3.460 102.31%
2021-02-20 6 10 3.00 7.00 4.440 57.66%
2021-02-13 6 10 3.00 7.00 4.610 51.84%
2021-02-06 6 10 3.00 7.00 4.510 55.21%
2021-01-08 7 10 3.00 6.71 3.100 116.45%
2021-01-02 7 10 3.00 6.71 2.800 139.64%
2020-12-26 7 10 3.00 6.71 2.920 129.79%
2020-12-19 7 10 3.00 6.71 3.000 123.67%
2020-12-09 7 10 3.00 6.71 2.815 138.37%
2020-12-07 7 10 3.00 6.71 3.040 120.72%
2020-11-28 7 10 3.00 6.71 3.390 97.94%
2020-11-17 7 10 3.00 6.71 2.730 145.79%
2020-10-23 7 10 3.00 6.71 3.180 111.01%
2020-09-03 7 10 3.00 6.86 NA NA%
2020-08-13 7 26 12.00 18.00 NA NA%
2020-07-19 8 26 12.00 17.25 NA NA%
2020-07-14 8 26 12.00 17.25 NA NA%
2020-05-05 8 26 11.00 17.12 NA NA%

AKBA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.62 1 5 1 0 0 8

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AKBA as an investment opportunity.

  • Akebia Therapeutics Inc's variance in analysts' estimates is less than 3.55% of all US stocks.
  • AKBA has a greater number of analysts covering the stock than 87.98% of stocks in the small market cap category.
  • AKBA has a higher average analyst price target than 12.09% of all US stocks.
  • AKBA has a higher upside potential (average analyst target price relative to current price) than 84.08% of all US stocks.

In the Pharmaceutical Products industry, SPRO, EVLO and CTMX are the three stocks most similar to Akebia Therapeutics Inc regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding AKBA using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7353 seconds.